Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Q8WG
|
||||
Former ID |
DIB006506
|
||||
Drug Name |
Tedalinab
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Pain [ICD9: 338, 356.0, 356.8,780; ICD10:G64, G90.0, R52, G89] | Phase 1 | [548356] | ||
Company |
Glenmark Pharmaceuticals Ltd
|
||||
Structure |
Download2D MOL |
||||
Formula |
C19H21F2N3O
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Agonist | [551201] | |
KEGG Pathway | Neuroactive ligand-receptor interaction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.